Get Real Time Here
| Open2.130 | Close2.120 |
| Vol / Avg.16.772K / 40.945K | Mkt Cap5.450M |
| Day Range2.060 - 2.150 | 52 Wk Range1.650 - 16.000 |
Agile Therapeutics Stock (NASDAQ:AGRX), Quotes and News Summary
Agile Therapeutics Stock (NASDAQ: AGRX) stock price, news, charts, stock research, profile.
| Open2.130 | Close2.120 |
| Vol / Avg.16.772K / 40.945K | Mkt Cap5.450M |
| Day Range2.060 - 2.150 | 52 Wk Range1.650 - 16.000 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.840 | -1.470 | 0.3700 | ||||
| REV | 5.270M | 6.662M | 1.392M |
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -3.480 | -3.10 | 0.3800 | ||||
| REV | 4.680M | 5.503M | 823.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-22 | Maxim Group | Naz Rahman | Upgrades | HoldBuy | Announces | - | 5.00 |
| 2023-06-26 | HC Wainwright & Co. | Oren Livnat | Reiterates | BuyBuy | Maintains | - | 12.00 |
| 2023-06-07 | HC Wainwright & Co. | Oren Livnat | Reiterates | BuyBuy | Maintains | - | 12.00 |
| 2022-12-30 | HC Wainwright & Co. | Oren Livnat | Maintains | Buy | Lowers | 5.00 | 3.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| AGRX | Agile Therapeutics | 2.85% | 5.5M |
| CING | Cingulate | 19.96% | 7.1M |
| SXTP | 60 Degrees | 12.47% | 3.8M |
| KPRX | Kiora Pharmaceuticals | -0.13% | 4M |
| UPC | Universe Pharmaceuticals | -0.1% | 3.5M |
How do I buy Agile Therapeutics (AGRX) stock?
You can purchase shares of Agile Therapeutics (NASDAQ: AGRX) through any online brokerage.
Who are Agile Therapeutics's (AGRX) competitors?
Other companies in Agile Therapeutics’s space includes: Cingulate (NASDAQ:CING), 60 Degrees (NASDAQ:SXTP), Kiora Pharmaceuticals (NASDAQ:KPRX), Universe Pharmaceuticals (NASDAQ:UPC) and Palisade Bio (NASDAQ:PALI).
What is the target price for Agile Therapeutics (AGRX) stock?
The latest price target for Agile Therapeutics (NASDAQ: AGRX) was reported by Maxim Group on Friday, September 22, 2023. The analyst firm set a price target for 5.00 expecting AGRX to rise to within 12 months (a possible 130.41% upside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Agile Therapeutics (AGRX)?
The stock price for Agile Therapeutics (NASDAQ: AGRX) is $2.17 last updated November 29, 2023 at 12:23 AM UTC.
Does Agile Therapeutics (AGRX) pay a dividend?
There is no dividend information for Agile Therapeutics.
When is Agile Therapeutics (NASDAQ:AGRX) reporting earnings?
Agile Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Agile Therapeutics (AGRX) going to split?
There is no upcoming split for Agile Therapeutics.
What sector and industry does Agile Therapeutics (AGRX) operate in?
Agile Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.